Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (261-270 of 501) with videos related to

Pageof 51
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and FosM L Handel, C K Watts, A deFazio, et al.
The Medical Journal of Australia|February 4, 2014
Pharmacometrics: an underused resource in Australian clinical researchVidya Perera, Michael J Dolton, Andrew J McLachlan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 13, 2014
Diabetes education: the experiences of young adults with type 1 diabetesJanice Wiley, Mary Westbrook, Janet Long, et al.
Inorganic Chemistry|October 23, 1996
Axial Site Occupancy by the Least Electronegative Ligands in Trigonal Bipyramidal Tetraoxyphosphoranes(1)Natalya V. Timosheva, A. Chandrasekaran, T. K. Prakasha, et al.
BMC Medical Informatics and Decision Making|January 6, 2018
Predicting 7-day, 30-day and 60-day all-cause unplanned readmission: a case study of a Sydney hospitalYashar Maali, Oscar Perez-Concha, Enrico Coiera, et al.
Internal Medicine Journal|July 4, 2014
iPad use at the bedside: a tool for engaging patients in care processes during ward rounds?M T Baysari, K Adams, E C Lehnbom, et al.
Diabetes Research and Clinical Practice|September 5, 2021
Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and EndocrinologistsTamara Y Milder, Sophie L Stocker, Melissa Baysari, et al.
Nephrology (Carlton, Vic.)|July 3, 2023
Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing softwareMaurizio Stefani, Kirsty Musgrave, Jacob Sevastos, et al.
Internal Medicine Journal|August 7, 2023
'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiationTamara Y Milder, Sophie L Stocker, Melissa T Baysari, et al.
European Journal of Clinical Pharmacology|August 5, 2019
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney diseaseTamara Y Milder, Sophie L Stocker, Dorit Samocha-Bonet, et al.
Pageof 51

Showing results (261-270 of 501) with videos related to

Sort By:
Pageof 51
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and FosM L Handel, C K Watts, A deFazio, et al.
The Medical Journal of Australia|February 4, 2014
Pharmacometrics: an underused resource in Australian clinical researchVidya Perera, Michael J Dolton, Andrew J McLachlan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 13, 2014
Diabetes education: the experiences of young adults with type 1 diabetesJanice Wiley, Mary Westbrook, Janet Long, et al.
Inorganic Chemistry|October 23, 1996
Axial Site Occupancy by the Least Electronegative Ligands in Trigonal Bipyramidal Tetraoxyphosphoranes(1)Natalya V. Timosheva, A. Chandrasekaran, T. K. Prakasha, et al.
BMC Medical Informatics and Decision Making|January 6, 2018
Predicting 7-day, 30-day and 60-day all-cause unplanned readmission: a case study of a Sydney hospitalYashar Maali, Oscar Perez-Concha, Enrico Coiera, et al.
Internal Medicine Journal|July 4, 2014
iPad use at the bedside: a tool for engaging patients in care processes during ward rounds?M T Baysari, K Adams, E C Lehnbom, et al.
Diabetes Research and Clinical Practice|September 5, 2021
Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and EndocrinologistsTamara Y Milder, Sophie L Stocker, Melissa Baysari, et al.
Nephrology (Carlton, Vic.)|July 3, 2023
Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing softwareMaurizio Stefani, Kirsty Musgrave, Jacob Sevastos, et al.
Internal Medicine Journal|August 7, 2023
'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiationTamara Y Milder, Sophie L Stocker, Melissa T Baysari, et al.
European Journal of Clinical Pharmacology|August 5, 2019
Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney diseaseTamara Y Milder, Sophie L Stocker, Dorit Samocha-Bonet, et al.
Pageof 51